Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

Characteristics of patients with AKI diagnosed using eKDIGO only by the decrease in sCr (deKDIGO) and no AKI. by Marina Wainstein (12437091)

DataSheet1_Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette sm... by Fiona Chapman (12096401)

Results for the asymmetric relationship between military expenditures and DOD energy consumption. by Ryan P. Thombs (9138968)

Subjects:

Coefficient plot of short-run effects. by Ryan P. Thombs (9138968)

Subjects:

Seven forecast scenarios. by Ryan P. Thombs (9138968)

Subjects:

Annual Difference in Energy Consumption Relative to Historical Median Change by 2032. by Ryan P. Thombs (9138968)

Subjects:

Coefficient plot of long-run effects. by Ryan P. Thombs (9138968)

Subjects:

Results for the asymmetric relationship between military expenditures and DOD energy consumption. by Ryan P. Thombs (9138968)

Subjects:

Time series of military expenditures and DOD energy consumption. by Ryan P. Thombs (9138968)

Subjects:

Forecast for each scenario, 2023-2032. by Ryan P. Thombs (9138968)

Subjects:

Deletion of the transmembrane helix promotes greater stability and biological activity. by Wei Yang (109917)

Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. by William C. Barley (8915282)

Subjects:

Regression estimates and incidence rate ratios from GLMER for number of papers (top) and coauthors (bottom). by William C. Barley (8915282)

Subjects:

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

Subjects:

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

Subjects:

Average purchase costs of 3GCs and all oral antimicrobials per 100 patient-days from Phases 1–4. by Naoya Itoh (6029276)

Subjects: